Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
This AI-Powered Laser Is Eliminating Weeds, No Chemicals Required
AI-powered lasers are helping farmers eliminate weeds without chemicals. Carbon Robotics CEO Paul Mikesell explains the technology shaping farming.
Is This the Phone That Finally Beats the iPhone? Samsung Thinks So
Samsung unveils the Galaxy Z Fold 8, Fold 8 Ultra, Flip 8, smarter AI, and upgraded wearables. Here's what matters and why Apple should be watching.
The Future of Fame: Inside TIME's 2026 TIME100 Creators List
TIME Editorial Director Lucy Feldman breaks down the 2026 TIME100 Creators list, the evolution of the creator economy, and what's next for digital media.
The AI Arms Race in Language Learning: How Babbel Plans to Stand Out
As AI transforms language learning, Babbel CEO Julie Hansen explains why technology works best alongside human connection, culture, and community.
The Odyssey's Record Run: What It Means for Hollywood
Can blockbuster movies and streaming thrive together? Paul Dergarabedian breaks down The Odyssey's record box office, Netflix's earnings, and Hollywood's future
The Odyssey Sails To A Record-breaking Debut
Christopher Nolan’s The Odyssey stormed into theaters with a massive $264 million global opening weekend, far exceeding expectations.
